Crossmark

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Crossref DOI link: https://doi.org/10.1038/s41374-022-00796-6

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Shafi, Saba

Aung, Thazin Nwe https://orcid.org/0000-0003-4150-0426
Xirou, Vasiliki

Gavrielatou, Niki

Vathiotis, Ioannis A.

Fernandez, Aileen

Moutafi, Myrto

Yaghoobi, Vesal

Herbst, Roy S.

Liu, Linda N.

Langermann, Sol

Rimm, David L. https://orcid.org/0000-0001-5820-4397
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50 CA196530)

NextCure Inc
License Information

Text and Data Mining valid from 2022-10-01

Text and Data Mining valid from 2022-10-01

Version of Record valid from 2023-10-07
More Information

This article is maintained by: Elsevier

Article Title: Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Journal Title: Laboratory Investigation

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41374-022-00796-6

Content Type: article

Copyright: © 2022 United States & Canadian Academy of Pathology.